AzTrials
AzTrials

Maxillary SinusPhase 4NCT04123860

Effect of Buccal Fat Pad and Platelet Rich Fibrin After Ultrasonic Hydrodynamic Maxillary Sinus Membrane Elevation

A Phase 4 study testing ultrasonic hydrodynamic maxillary sinus lift buccal pad fat and ultrasonic hydrodynamic maxillary sinus lift platelet rich fibrin in people with Maxillary Sinus, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Placing implants in the posterior maxillary area has the drawback of working with scarce, poor quality bone in a significant percentage of cases. Numerous advanced surgical techniques have been developed to overcome the difficulties associated with these limitations. Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Maxillary Sinus
What is being tested?
ultrasonic hydrodynamic maxillary sinus lift buccal pad fat and ultrasonic hydrodynamic maxillary sinus lift platelet rich fibrin
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
No sites listed yet
Study dates
10 Nov 2019to 10 Dec 2021
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • edentulous maxilla in premolar-molar areas with a residual ridge height of 5-9mm.

Who cannot join

  • sinuses with septa in the operated area, polyps, sequelae of fistulas or fractures.
  • Cases for current study will be selected free from local pathosis. Patients will be free from any systemic disease that could affect their reparative power.

Trial locations and contacts

No sites are listed yet.

Mostafa Ah El Masry, msc contact

00201221953838

mostafa.elmasry@hotmail.com

About this study

Official title: Comparative Study Between Effect of Buccal Fat Pad and Platelet Rich Fibrin After Ultrasonic Hydrodynamic Maxillary Sinus Membrane Elevation

Placing implants in the posterior maxillary area has the drawback of working with scarce, poor quality bone in a significant percentage of cases. Numerous advanced surgical techniques have been developed to overcome the difficulties associated with these limitations. Subsequent to reports on the elevation of the maxillary sinus through the lateral approach, there were reports on the use of the crestal approach, which is less aggressive but requires a minimal amount of bone. Furthermore, it is more sensitive to operator technique, as the integrity of the sinus membrane is checked indirectly. The main advantage of this new technique, Intralift, is that it does not require a minimum amount of crestal bone (indeed, the smaller the width of the crestal bone, the better this technique is performed). The possibility of damage to the sinus membrane is minimized by using ultrasound based hydrodynamic pressure to lift it, while applying a very non-aggressive crestal approach. Conclusions: We believe that this technique is an advance in the search for less traumatic and aggressive techniques, which is the hallmark of current surgery The buccal fat pad appears at 3 months in utero and continuously grows until birth (9). It protrudes at the anterior border of the masseter muscle and extends to the parotid duct, where it rests on the buccopharyngeal fascia, which covers the buccinator muscle. There is little change in the volume of buccal fat during aging, and it is approximately 10 mL

PRF is a natural fibrin-based biomaterial prepared from an anticoagulant-free blood harvest without any artificial biochemical modification that allows obtaining fibrin membranes enriched with platelets and growth factors

Read the detailed description

Placing implants in the posterior maxillary area has the drawback of working with scarce, poor quality bone in a significant percentage of cases. Numerous advanced surgical techniques have been developed to overcome the difficulties associated with these limitations. Subsequent to reports on the elevation of the maxillary sinus through the lateral approach, there were reports on the use of the crestal approach, which is less aggressive but requires a minimal amount of bone. Furthermore, it is more sensitive to operator technique, as the integrity of the sinus membrane is checked indirectly. The main advantage of this new technique, Intralift, is that it does not require a minimum amount of crestal bone (indeed, the smaller the width of the crestal bone, the better this technique is performed). The possibility of damage to the sinus membrane is minimized by using ultrasound based hydrodynamic pressure to lift it, while applying a very non-aggressive crestal approach. Conclusions: We believe that this technique is an advance in the search for less traumatic and aggressive techniques, which is the hallmark of current surgery The buccal fat pad appears at 3 months in utero and continuously grows until birth (9). It protrudes at the anterior border of the masseter muscle and extends to the parotid duct, where it rests on the buccopharyngeal fascia, which covers the buccinator muscle. There is little change in the volume of buccal fat during aging, and it is approximately 10 mL

PRF is a natural fibrin-based biomaterial prepared from an anticoagulant-free blood harvest without any artificial biochemical modification that allows obtaining fibrin membranes enriched with platelets and growth factors

Sinus lifting procedures are performed routinely to provide the required height of proper and stable bone tissue around the dental implants to be inserted. The surgical technique of maxillary sinus Schneiderian membrane (MSSM) lifting with immediate/simultaneous installation of dental implants, generally results in significant bone formation. The recently reported graftless MSSM elevation procedure and the subsequent augmentation of bone have greatly changed our perspective of bone neoformation potential. The blood clot formed under the lifted MSSM appears to be of critical importance in bone neoformation potential, precluding the need for exogenous graft materials

In elevation with the rotary technique, the main intraoperative complication is perforation of Schneider's membrane, which is observed in between 10-35% of all such operations , and which usually occurs in the osteotomy drilling phase while preparing the window for access to the sinus . With the purpose of reducing the risk of perforating Schneider's membrane, vestibule osteotomy using ultrasound has been proposed, as this reduces the risk of soft tissue damage and percentage membrane perforation to 7%. Some studies in the literature are preliminary descriptions of the technique, while others present isolated cases and others in turn report case series - no significant differences being observed between the two techniques

Conditions
Maxillary Sinus
Being tested
ultrasonic hydrodynamic maxillary sinus lift buccal pad fat, ultrasonic hydrodynamic maxillary sinus lift platelet rich fibrin
Keywords
intralift, maxillery sinus lift, hydrodynamic ultrasonic, buccal pad fat, platelet rich fibrin, immediate dental implant

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrasonic hydrodynamic maxillary sinus lift buccal pad fatOther

    Also called intralift technique maxillary sinus lift

    ultrasonic hydrodynamic maxillary sinus lift and buccal fat pad as grafting material followed by immediate implant

  • ultrasonic hydrodynamic maxillary sinus lift platelet rich fibrinOther

    Also called intralift technique maxillary sinus lift

    ultrasonic hydrodynamic maxillary sinus lift and platelet rich fibrin as grafting material followed by immediate implant

Study groups in NCT04123860
Study groupRoleWhat they receive
buccal fat padExperimentalwill undergo sinus lifting using intralift technique then placement of buccal fat pad followed by immediate implant placement.
Receives: Other: ultrasonic hydrodynamic maxillary sinus lift buccal pad fat
prfActive comparatorwill undergo sinus lifting using intralift technique the prpration of PRF and immediate implant placement.
Receives: Other: ultrasonic hydrodynamic maxillary sinus lift platelet rich fibrin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bone height gain

    amount of bone gain

    Measured: 6 month

Secondary outcomes (1)
  1. bone density

    change in bone density

    Measured: 6 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Oct 2019
  2. Study start10 Nov 2019 (estimated)
  3. Primary completion10 Dec 2020 (estimated)
  4. Study completion10 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
it is randomized clinical trail
Masking
Single blind
Who is masked
Participant
Enrolment
12 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04123860
Sponsor's protocol ID
oral surgery 14
Status last verified
Oct 2019
First submitted
10 Oct 2019
Last updated
11 Oct 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: i will check with my study chair

Publications

  • Kim MK, Han W, Kim SG. The use of the buccal fat pad flap for oral reconstruction. Maxillofac Plast Reconstr Surg. 2017 Feb 25;39(1):5. doi: 10.1186/s40902-017-0105-5. eCollection 2017 Dec.

    PubMed 28286743
  • Lo Giudice G, Iannello G, Terranova A, Lo Giudice R, Pantaleo G, Cicciu M. Transcrestal Sinus Lift Procedure Approaching Atrophic Maxillary Ridge: A 60-Month Clinical and Radiological Follow-Up Evaluation. Int J Dent. 2015;2015:261652. doi: 10.1155/2015/261652. Epub 2015 Sep 16.

    PubMed 26451145
  • Kumar KR, Genmorgan K, Abdul Rahman SM, Rajan MA, Kumar TA, Prasad VS. Role of plasma-rich fibrin in oral surgery. J Pharm Bioallied Sci. 2016 Oct;8(Suppl 1):S36-S38. doi: 10.4103/0975-7406.191963.

    PubMed 27829743
  • Velazquez-Cayon R, Romero-Ruiz MM, Torres-Lagares D, Perez-Dorao B, Wainwright M, Abalos-Labruzzi C, Gutierrez-Perez JL. Hydrodynamic ultrasonic maxillary sinus lift: review of a new technique and presentation of a clinical case. Med Oral Patol Oral Cir Bucal. 2012 Mar 1;17(2):e271-5. doi: 10.4317/medoral.17430.

    PubMed 22143696
  • Penarrocha-Diago M, Penarrocha-Diago M, Sanchez-Recio C, Penarrocha-Oltra D, Romero-Millan J. Osteotomy in direct sinus lift. A comparative study of the rotary technique and ultrasound. Med Oral Patol Oral Cir Bucal. 2012 May 1;17(3):e457-61. doi: 10.4317/medoral.17599.

    PubMed 22143735

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing ultrasonic hydrodynamic maxillary sinus lift buccal pad fat and ultrasonic hydrodynamic maxillary sinus lift platelet rich fibrin in people with Maxillary Sinus, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mostafa Ah El Masry, msc (00201221953838, mostafa.elmasry@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bone height gain (time frame: 6 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04123860, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Oct 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in